miércoles, 15 de febrero de 2017

Endocrine therapy for hormone receptor–positive metastatic breast cancer: American Society of Clinical Oncology guideline. | National Guideline Clearinghouse

Endocrine therapy for hormone receptor–positive metastatic breast cancer: American Society of Clinical Oncology guideline. | National Guideline Clearinghouse

ngc

American Society of Clinical Oncology




  • GUIDELINE SUMMARY
    •  
  • NGC:011061
    •  
  • 2016 SEP 1

Endocrine therapy for hormone receptor–positive metastatic breast cancer: American Society of Clinical Oncology guideline.

Publicado por en

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)